Grail's Slump Enters Week: Navigating Biotech's Setback
Grail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
The debate between points and cash back is ongoing. Understand the benefits of each to determine which suits you best.
28,655 articlesGrail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Solana faces a sharp pullback as SOL tests pivotal support levels. A new solana (sol) price alert highlights mounting...
With gas prices hovering near $4 per gallon, diners are tightening belts, and restaurant sales are cooling. Analysts ...
Bitcoin nudges toward the 85K mark as institutional flows restart and inflation data stirs volatility. The bitcoin (b...
Lawmakers unveil a bill to raise the ethanol blend to 15% year-round, hoping to shave pump costs and support farmers....
The ProShares Ultra Technology ETF fell sharply on Friday as NVIDIA and Broadcom headlines collided with tech stocks,...
As AI spending shifts from hype to heavy borrowing, Goldman Sachs warns AI's debt tsunami may tighten credit markets....
Beaten-down SaaS shares stage a comeback as AI fears fade. This report explains why the AI panic didn’t kill saas aft...
When uncertainty rises, smart investors turn to simple, high-quality solutions. This guide explains why the Vanguard ...
Turning 55 can spark worries about retirement savings. This guide shows you practical steps to catch up, with real-wo...
As factories brace for a new wave of automation and infrastructure spending, the materials sector could lead gains. T...
When a company director trims a stake, investors ask: what does it mean for the stock? This guide walks you through h...